8-K filing — Lifevantage Corp (LFVN)
Filed: 2026-10-05 AccNo: 0001193125-26-414122 Size: 146 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Stocks · News reference
LifeVantage Plans To Not Issue FY27 Outlook Due To Recent CEO Transition
LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced due to the recent transition in the Chief
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026
LifeVantage Corporation announced that CEO Terrence Moorehead and CFO Carl Aure will participate in the WTR Virtual Insights Conference on September 23, 2026. The webcast presentation will begin at 1:30 p.m. Eastern Time and is open to all investors through the company's Investor Relations website.
Lake Street Maintains Hold on Lifevantage, Raises Price Target to $6
Lake Street analyst Ryan Meyers maintains Lifevantage (NASDAQ:LFVN) with a Hold and raises the price target from $5 to $6.
Lifevantage Q4 2026 Earnings Call Transcript
On Thursday, Lifevantage (NASDAQ:LFVN) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access